Skip to main content
Erschienen in: Virchows Archiv 1/2013

01.01.2013 | Review and Perspectives

Interstitial lung diseases—can pathologists arrive at an etiology-based diagnosis? A critical update

verfasst von: Helmut H. Popper

Erschienen in: Virchows Archiv | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Interstitial lung diseases (ILD) encompass a group of diseases with a wide range of etiologies and a variety of tissue reactions within the lung. In many instances, a careful evaluation of the tissue reactions will result in a specific diagnosis or at least in a narrow range of differentials, which will assist the clinician to arrive at a definite diagnosis, when combining our interpretation with the clinical presentation of the patient and high-resolution computed tomography. In this review, we will exclude granulomatous pneumonias as well as vascular diseases (primary arterial pulmonary hypertension and vasculitis); however, pulmonary hypertension as a complication of interstitial processes will be mentioned. Few entities of pneumoconiosis presenting as an interstitial process will be included, whereas those with granulomatous reactions will be excluded. Drug reactions will be touched on within interstitial pneumonias, but will not be a major focus. In contrast to the present-day preferred descriptive pattern recognition, it is the author’s strong belief that pathologists should always try to dig out the etiology from a tissue specimen and not being satisfied with just a pattern description. It is the difference of sorting tissue reactions into boxes by their main pattern, without recognizing minor or minute reactions, which sometimes will guide one to the correct etiology-oriented interpretation. In the author’s personal perspective, tissue reactions can even be sorted by their timeliness, and therefore, ordered by the time of appearance, providing an insight into the pathogenesis and course of a disease. Also, underlying immune mechanisms will be discussed briefly as far as they are essential to understand the disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Liebow A, Carrington C (1969) The interstitial pneumonias. Frontiers of pulmonary radiology pathophysiologic, roentgenographic and radioisotopic considerations. Grune & Stratton, Orlando Liebow A, Carrington C (1969) The interstitial pneumonias. Frontiers of pulmonary radiology pathophysiologic, roentgenographic and radioisotopic considerations. Grune & Stratton, Orlando
2.
Zurück zum Zitat Katzenstein AL (1993) Idiopathic interstitial pneumonia: classification and diagnosis. Monogr Pathol 36:1–31PubMed Katzenstein AL (1993) Idiopathic interstitial pneumonia: classification and diagnosis. Monogr Pathol 36:1–31PubMed
3.
Zurück zum Zitat Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157(4 Pt 1):1301–1315PubMed Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157(4 Pt 1):1301–1315PubMed
4.
Zurück zum Zitat Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA, King TE Jr, Lynch JP 3rd, Hegele R, Waldron J, Colby TV, Hogg JC (2003) Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 124(4):1215–1223PubMedCrossRef Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA, King TE Jr, Lynch JP 3rd, Hegele R, Waldron J, Colby TV, Hogg JC (2003) Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 124(4):1215–1223PubMedCrossRef
5.
Zurück zum Zitat Johkoh T, Muller NL, Colby TV, Ichikado K, Taniguchi H, Kondoh Y, Fujimoto K, Kinoshita M, Arakawa H, Yamada H, Suga M, Ando M, Koyama M, Nakamura H (2002) Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 225(1):199–204PubMedCrossRef Johkoh T, Muller NL, Colby TV, Ichikado K, Taniguchi H, Kondoh Y, Fujimoto K, Kinoshita M, Arakawa H, Yamada H, Suga M, Ando M, Koyama M, Nakamura H (2002) Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 225(1):199–204PubMedCrossRef
6.
Zurück zum Zitat Travis WD, Matsui K, Moss J, Ferrans VJ (2000) Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24(1):19–33PubMedCrossRef Travis WD, Matsui K, Moss J, Ferrans VJ (2000) Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24(1):19–33PubMedCrossRef
7.
Zurück zum Zitat Abati A, Cajigas A, Holland SM, Solomon D (1996) Chronic granulomatous disease of childhood: respiratory cytology. Diagn Cytopathol 15(2):98–102PubMedCrossRef Abati A, Cajigas A, Holland SM, Solomon D (1996) Chronic granulomatous disease of childhood: respiratory cytology. Diagn Cytopathol 15(2):98–102PubMedCrossRef
8.
Zurück zum Zitat Tabatowski K, Roggli VL, Fulkerson WJ, Langley RL, Benning T, Johnston WW (1988) Giant cell interstitial pneumonia in a hard-metal worker. Cytologic, histologic and analytical electron microscopic investigation. Acta Cytol 32(2):240–246PubMed Tabatowski K, Roggli VL, Fulkerson WJ, Langley RL, Benning T, Johnston WW (1988) Giant cell interstitial pneumonia in a hard-metal worker. Cytologic, histologic and analytical electron microscopic investigation. Acta Cytol 32(2):240–246PubMed
9.
Zurück zum Zitat Travis W, King T, Bateman E et al (2001) American Thoracic Society/European International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. ATS/ERS joint statement adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee. Am J Respir Crit Care Med 165(2):277–304 Travis W, King T, Bateman E et al (2001) American Thoracic Society/European International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. ATS/ERS joint statement adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee. Am J Respir Crit Care Med 165(2):277–304
10.
Zurück zum Zitat Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824. doi:10.1164/rccm.2009-040GL PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824. doi:10.​1164/​rccm.​2009-040GL PubMedCrossRef
12.
Zurück zum Zitat Cha SI, Groshong SD, Frankel SK, Edelman BL, Cosgrove GP, Terry-Powers JL, Remigio LK, Curran-Everett D, Brown KK, Cool CD, Riches DW (2010) Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 42(2):140–148. doi:10.1165/rcmb.2008-0419OC PubMedCrossRef Cha SI, Groshong SD, Frankel SK, Edelman BL, Cosgrove GP, Terry-Powers JL, Remigio LK, Curran-Everett D, Brown KK, Cool CD, Riches DW (2010) Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 42(2):140–148. doi:10.​1165/​rcmb.​2008-0419OC PubMedCrossRef
14.
Zurück zum Zitat White ES, Lazar MH, Thannickal VJ (2003) Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 201(3):343–354PubMedCrossRef White ES, Lazar MH, Thannickal VJ (2003) Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 201(3):343–354PubMedCrossRef
15.
Zurück zum Zitat Lepparanta O, Pulkkinen V, Koli K, Vahatalo R, Salmenkivi K, Kinnula VL, Heikinheimo M, Myllarniemi M (2010) Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 42(5):626–632. doi:10.1165/rcmb.2009-0021OC PubMedCrossRef Lepparanta O, Pulkkinen V, Koli K, Vahatalo R, Salmenkivi K, Kinnula VL, Heikinheimo M, Myllarniemi M (2010) Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 42(5):626–632. doi:10.​1165/​rcmb.​2009-0021OC PubMedCrossRef
16.
Zurück zum Zitat Chibbar R, Shih F, Baga M, Torlakovic E, Ramlall K, Skomro R, Cockcroft DW, Lemire EG (2004) Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol 17(8):973–980PubMedCrossRef Chibbar R, Shih F, Baga M, Torlakovic E, Ramlall K, Skomro R, Cockcroft DW, Lemire EG (2004) Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol 17(8):973–980PubMedCrossRef
18.
Zurück zum Zitat Bocchino M, Agnese S, Fagone E, Svegliati S, Grieco D, Vancheri C, Gabrielli A, Sanduzzi A, Avvedimento EV (2010) Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One 5(11):e14003. doi:10.1371/journal.pone.0014003 PubMedCrossRef Bocchino M, Agnese S, Fagone E, Svegliati S, Grieco D, Vancheri C, Gabrielli A, Sanduzzi A, Avvedimento EV (2010) Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One 5(11):e14003. doi:10.​1371/​journal.​pone.​0014003 PubMedCrossRef
19.
Zurück zum Zitat Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS (2011) Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis 28(2):102–112PubMed Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS (2011) Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis 28(2):102–112PubMed
21.
Zurück zum Zitat Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb M (2009) Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(7):588–594. doi:10.1164/rccm.200810-1534OC PubMedCrossRef Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb M (2009) Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(7):588–594. doi:10.​1164/​rccm.​200810-1534OC PubMedCrossRef
22.
Zurück zum Zitat Chilosi M, Zamo A, Doglioni C, Reghellin D, Lestani M, Montagna L, Pedron S, Ennas MG, Cancellieri A, Murer B, Poletti V (2006) Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 7:95. doi:10.1186/1465-9921-7-95 PubMedCrossRef Chilosi M, Zamo A, Doglioni C, Reghellin D, Lestani M, Montagna L, Pedron S, Ennas MG, Cancellieri A, Murer B, Poletti V (2006) Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 7:95. doi:10.​1186/​1465-9921-7-95 PubMedCrossRef
23.
Zurück zum Zitat Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE (2010) Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 299(4):L442–L452. doi:10.1152/ajplung.00026.2010 PubMedCrossRef Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE (2010) Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 299(4):L442–L452. doi:10.​1152/​ajplung.​00026.​2010 PubMedCrossRef
24.
Zurück zum Zitat Frankel SK, Cosgrove GP, Cha SI, Cool CD, Wynes MW, Edelman BL, Brown KK, Riches DW (2006) TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol 34(3):293–304. doi:10.1165/rcmb.2005-0155OC PubMedCrossRef Frankel SK, Cosgrove GP, Cha SI, Cool CD, Wynes MW, Edelman BL, Brown KK, Riches DW (2006) TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol 34(3):293–304. doi:10.​1165/​rcmb.​2005-0155OC PubMedCrossRef
25.
Zurück zum Zitat Kinnula VL, Hodgson UA, Lakari EK, Tan RJ, Sormunen RT, Soini YM, Kakko SJ, Laitinen TH, Oury TD, Paakko PK (2006) Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 49(1):66–74. doi:10.1111/j.1365-2559.2006.02470.x PubMedCrossRef Kinnula VL, Hodgson UA, Lakari EK, Tan RJ, Sormunen RT, Soini YM, Kakko SJ, Laitinen TH, Oury TD, Paakko PK (2006) Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 49(1):66–74. doi:10.​1111/​j.​1365-2559.​2006.​02470.​x PubMedCrossRef
27.
Zurück zum Zitat Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, DeRisi J, Ganem D, Collard HR (2011) Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183(12):1698–1702. doi:10.1164/rccm.201010-1752OC PubMedCrossRef Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, DeRisi J, Ganem D, Collard HR (2011) Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183(12):1698–1702. doi:10.​1164/​rccm.​201010-1752OC PubMedCrossRef
28.
Zurück zum Zitat Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157(1):199–203PubMed Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157(1):199–203PubMed
29.
Zurück zum Zitat Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF (1998) Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158(4):1286–1293PubMed Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF (1998) Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158(4):1286–1293PubMed
30.
Zurück zum Zitat Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M (2003) Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 123(4):1096–1103PubMedCrossRef Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M (2003) Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 123(4):1096–1103PubMedCrossRef
31.
Zurück zum Zitat Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165(12):1581–1586PubMedCrossRef Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165(12):1581–1586PubMedCrossRef
32.
Zurück zum Zitat Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M (2002) The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19(2):121–127PubMed Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M (2002) The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19(2):121–127PubMed
33.
Zurück zum Zitat Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG (2004) Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44(6):585–596PubMedCrossRef Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG (2004) Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44(6):585–596PubMedCrossRef
34.
Zurück zum Zitat Yoshinouchi T, Ohtsuki Y, Fujita J, Yamadori I, Bandoh S, Ishida T, Ueda R (2005) Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 26(2):121–125. doi:10.1007/s00296-004-0527-0 PubMedCrossRef Yoshinouchi T, Ohtsuki Y, Fujita J, Yamadori I, Bandoh S, Ishida T, Ueda R (2005) Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 26(2):121–125. doi:10.​1007/​s00296-004-0527-0 PubMedCrossRef
35.
Zurück zum Zitat Jinta T, Miyazaki Y, Kishi M, Akashi T, Takemura T, Inase N, Yoshizawa Y (2010) The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol 134(4):613–620. doi:10.1309/AJCPK8RPQX7TQRQC PubMedCrossRef Jinta T, Miyazaki Y, Kishi M, Akashi T, Takemura T, Inase N, Yoshizawa Y (2010) The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol 134(4):613–620. doi:10.​1309/​AJCPK8RPQX7TQRQC​ PubMedCrossRef
36.
Zurück zum Zitat Martin N, Innes JA, Lambert CM, Turnbull CM, Wallace WA (2007) Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol 34(9):1934–1937PubMed Martin N, Innes JA, Lambert CM, Turnbull CM, Wallace WA (2007) Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol 34(9):1934–1937PubMed
37.
Zurück zum Zitat Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM (1999) A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160(3):899–905PubMed Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM (1999) A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160(3):899–905PubMed
38.
Zurück zum Zitat Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H (2005) Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 32(1):58–64PubMed Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H (2005) Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 32(1):58–64PubMed
39.
Zurück zum Zitat Tanaka N, Newell JD, Brown KK, Cool CD, Lynch DA (2004) Collagen vascular disease-related lung disease: high-resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 28(3):351–360PubMedCrossRef Tanaka N, Newell JD, Brown KK, Cool CD, Lynch DA (2004) Collagen vascular disease-related lung disease: high-resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 28(3):351–360PubMedCrossRef
40.
Zurück zum Zitat Popper HH (2002) Bronchiolitis obliterans. Organizing pneumonia. Verh Dtsch Ges Pathol 86:101–106PubMed Popper HH (2002) Bronchiolitis obliterans. Organizing pneumonia. Verh Dtsch Ges Pathol 86:101–106PubMed
41.
Zurück zum Zitat Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183 Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183
42.
Zurück zum Zitat Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219PubMedCrossRef Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219PubMedCrossRef
43.
Zurück zum Zitat Myers JL, Katzenstein AL (1988) Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia. Am J Pathol 132(1):102–109PubMed Myers JL, Katzenstein AL (1988) Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia. Am J Pathol 132(1):102–109PubMed
44.
Zurück zum Zitat Uner AH, Rozum-Slota B, Katzenstein AL (1996) Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener’s granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 20(7):794–801PubMedCrossRef Uner AH, Rozum-Slota B, Katzenstein AL (1996) Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener’s granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 20(7):794–801PubMedCrossRef
45.
Zurück zum Zitat Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T (2007) Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol 26(9):1585–1589PubMedCrossRef Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T (2007) Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol 26(9):1585–1589PubMedCrossRef
47.
Zurück zum Zitat Hamman L, Rich AR (1935) Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 51:154–163PubMed Hamman L, Rich AR (1935) Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 51:154–163PubMed
48.
Zurück zum Zitat Popper H, Juettner F, Pinter J (1986) The gastric juice aspiration syndrome (Mendelson syndrome). Aspects of pathogenesis and treatment in the pig. Virchows Arch A Pathol Anat Histopathol 409(1):105–117PubMedCrossRef Popper H, Juettner F, Pinter J (1986) The gastric juice aspiration syndrome (Mendelson syndrome). Aspects of pathogenesis and treatment in the pig. Virchows Arch A Pathol Anat Histopathol 409(1):105–117PubMedCrossRef
49.
Zurück zum Zitat Poletti V, Kitaichi M (2000) Facts and controversies in the classification of idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 17(3):229–238PubMed Poletti V, Kitaichi M (2000) Facts and controversies in the classification of idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 17(3):229–238PubMed
50.
51.
Zurück zum Zitat Voulgarelis M, Moutsopoulos HM (2003) Lymphoproliferation in autoimmunity and Sjogren’s syndrome. Curr Rheumatol Rep 5(4):317–323PubMedCrossRef Voulgarelis M, Moutsopoulos HM (2003) Lymphoproliferation in autoimmunity and Sjogren’s syndrome. Curr Rheumatol Rep 5(4):317–323PubMedCrossRef
53.
Zurück zum Zitat Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T (2005) Idiopathic non-specific interstitial pneumonia: as an “autoimmune interstitial pneumonia”. Respir Med 99(2):234–240PubMedCrossRef Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T (2005) Idiopathic non-specific interstitial pneumonia: as an “autoimmune interstitial pneumonia”. Respir Med 99(2):234–240PubMedCrossRef
55.
Zurück zum Zitat Fellbaum C, Domej W, Popper H (1989) Rheumatoid arthritis with extensive lung lesions. Thorax 44(1):70–71PubMedCrossRef Fellbaum C, Domej W, Popper H (1989) Rheumatoid arthritis with extensive lung lesions. Thorax 44(1):70–71PubMedCrossRef
56.
Zurück zum Zitat Vallbracht II, Popper HH, Rieber J, Nowak F, Gallenberger S, Piper B, Helmke K (2005) Lethal pneumonitis under leflunomide therapy. Rheumatology (Oxford) 44(12):1580–1581CrossRef Vallbracht II, Popper HH, Rieber J, Nowak F, Gallenberger S, Piper B, Helmke K (2005) Lethal pneumonitis under leflunomide therapy. Rheumatology (Oxford) 44(12):1580–1581CrossRef
57.
Zurück zum Zitat Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF (2005) The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology (Oxford) 44(1):61–66CrossRef Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF (2005) The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology (Oxford) 44(1):61–66CrossRef
58.
Zurück zum Zitat Zimmer C, Beiderlinden M, Peters J (2006) Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis. Clin Rheumatol 25(3):430–432PubMedCrossRef Zimmer C, Beiderlinden M, Peters J (2006) Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis. Clin Rheumatol 25(3):430–432PubMedCrossRef
59.
Zurück zum Zitat Garcia Campelo MR, Alonso Curbera G, Aparicio Gallego G, Grande Pulido E, Anton Aparicio LM (2011) Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin Transl Oncol 13(2):77–83PubMedCrossRef Garcia Campelo MR, Alonso Curbera G, Aparicio Gallego G, Grande Pulido E, Anton Aparicio LM (2011) Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin Transl Oncol 13(2):77–83PubMedCrossRef
60.
Zurück zum Zitat Koch AE (2007) The pathogenesis of rheumatoid arthritis. Am J Orthop (Belle Mead NJ) 36(7 Suppl):5–8 Koch AE (2007) The pathogenesis of rheumatoid arthritis. Am J Orthop (Belle Mead NJ) 36(7 Suppl):5–8
61.
Zurück zum Zitat Haupt HM, Moore GW, Hutchins GM (1981) The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 71(5):791–798PubMedCrossRef Haupt HM, Moore GW, Hutchins GM (1981) The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 71(5):791–798PubMedCrossRef
62.
Zurück zum Zitat Lee JG, Joo KW, Chung WK, Jung YC, Zheung SH, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Lee JS (2001) Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 55(4):282–288PubMed Lee JG, Joo KW, Chung WK, Jung YC, Zheung SH, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Lee JS (2001) Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 55(4):282–288PubMed
64.
Zurück zum Zitat Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38(6):893–902. doi:10.1016/j.humpath.2006.11.022 PubMedCrossRef Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38(6):893–902. doi:10.​1016/​j.​humpath.​2006.​11.​022 PubMedCrossRef
65.
Zurück zum Zitat Weng CT, Chung TJ, Liu MF, Weng MY, Lee CH, Chen JY, Wu AB, Lin BW, Luo CY, Hsu SC, Lee BF, Tsai HM, Chao SC, Wang JY, Chen TY, Chen CW, Chang HY, Wang CR (2011) A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern Taiwan. Lupus 20(8):876–885. doi:10.1177/0961203311401458 PubMedCrossRef Weng CT, Chung TJ, Liu MF, Weng MY, Lee CH, Chen JY, Wu AB, Lin BW, Luo CY, Hsu SC, Lee BF, Tsai HM, Chao SC, Wang JY, Chen TY, Chen CW, Chang HY, Wang CR (2011) A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern Taiwan. Lupus 20(8):876–885. doi:10.​1177/​0961203311401458​ PubMedCrossRef
67.
Zurück zum Zitat Tsukumo S, Yasutomo K (2004) DNaseI in pathogenesis of systemic lupus erythematosus. Clin Immunol 113(1):14–18PubMedCrossRef Tsukumo S, Yasutomo K (2004) DNaseI in pathogenesis of systemic lupus erythematosus. Clin Immunol 113(1):14–18PubMedCrossRef
68.
69.
Zurück zum Zitat Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34(2):501–537PubMedCrossRef Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34(2):501–537PubMedCrossRef
71.
Zurück zum Zitat Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghavan S, Bishop AE, Romanska HM, Pantelidis P, Black CM, Du Bois RM (2003) Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167(3):438–443PubMedCrossRef Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghavan S, Bishop AE, Romanska HM, Pantelidis P, Black CM, Du Bois RM (2003) Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167(3):438–443PubMedCrossRef
72.
Zurück zum Zitat Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, Black CM, Laurent GJ, Davies BH, Jeffery PK et al (1995) Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 151(5):1604–1612PubMed Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, Black CM, Laurent GJ, Davies BH, Jeffery PK et al (1995) Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 151(5):1604–1612PubMed
73.
Zurück zum Zitat Takehara K (2003) Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 30(4):755–759PubMed Takehara K (2003) Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 30(4):755–759PubMed
74.
Zurück zum Zitat Castello-Cros R, Whitaker-Menezes D, Molchansky A, Purkins G, Soslowsky LJ, Beason DP, Sotgia F, Iozzo RV, Lisanti MP (2011) Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle 10(13):2140–2150PubMedCrossRef Castello-Cros R, Whitaker-Menezes D, Molchansky A, Purkins G, Soslowsky LJ, Beason DP, Sotgia F, Iozzo RV, Lisanti MP (2011) Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle 10(13):2140–2150PubMedCrossRef
77.
78.
Zurück zum Zitat Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD (2006) Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Investig 116(12):3183–3194. doi:10.1172/JCI28756 PubMedCrossRef Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD (2006) Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Investig 116(12):3183–3194. doi:10.​1172/​JCI28756 PubMedCrossRef
79.
Zurück zum Zitat Nguyen CQ, Cornelius JG, Cooper L, Neff J, Tao J, Lee BH, Peck AB (2008) Identification of possible candidate genes regulating Sjogren’s syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy. Arthritis Res Ther 10(6):R137. doi:10.1186/ar2560 PubMedCrossRef Nguyen CQ, Cornelius JG, Cooper L, Neff J, Tao J, Lee BH, Peck AB (2008) Identification of possible candidate genes regulating Sjogren’s syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy. Arthritis Res Ther 10(6):R137. doi:10.​1186/​ar2560 PubMedCrossRef
81.
Zurück zum Zitat Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH (2006) T cell epitope mimicry in antiglomerular basement membrane disease. J Immunol 176(2):1252–1258PubMed Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH (2006) T cell epitope mimicry in antiglomerular basement membrane disease. J Immunol 176(2):1252–1258PubMed
82.
Zurück zum Zitat MacDonald BA, Sund M, Grant MA, Pfaff KL, Holthaus K, Zon LI, Kalluri R (2006) Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome. Blood 107(5):1908–1915PubMedCrossRef MacDonald BA, Sund M, Grant MA, Pfaff KL, Holthaus K, Zon LI, Kalluri R (2006) Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome. Blood 107(5):1908–1915PubMedCrossRef
83.
84.
Zurück zum Zitat Sharma OP (2001) Unusual systemic disorders associated with interstitial lung disease. Curr Opin Pulm Med 7(5):291–294PubMedCrossRef Sharma OP (2001) Unusual systemic disorders associated with interstitial lung disease. Curr Opin Pulm Med 7(5):291–294PubMedCrossRef
85.
Zurück zum Zitat Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Fujimura M, Nakanuma Y (2005) IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 36(7):710–717PubMedCrossRef Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Fujimura M, Nakanuma Y (2005) IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 36(7):710–717PubMedCrossRef
86.
87.
Zurück zum Zitat Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 26(7):716–724PubMedCrossRef Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 26(7):716–724PubMedCrossRef
88.
Zurück zum Zitat Churg A, Myers J, Suarez T, Gaxiola M, Estrada A, Mejia M, Selman M (2004) Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 28(1):62–68PubMedCrossRef Churg A, Myers J, Suarez T, Gaxiola M, Estrada A, Mejia M, Selman M (2004) Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 28(1):62–68PubMedCrossRef
89.
Zurück zum Zitat Koethe SM, Kuhnmuench JR, Becker CG (2000) Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157(5):1735–1743PubMedCrossRef Koethe SM, Kuhnmuench JR, Becker CG (2000) Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157(5):1735–1743PubMedCrossRef
90.
Zurück zum Zitat Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 151(1):145–150PubMed Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 151(1):145–150PubMed
91.
Zurück zum Zitat Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 60(6):385–396CrossRef Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 60(6):385–396CrossRef
92.
Zurück zum Zitat Sundar KM, Gosselin MV, Chung HL, Cahill BC (2003) Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 123(5):1673–1683PubMedCrossRef Sundar KM, Gosselin MV, Chung HL, Cahill BC (2003) Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 123(5):1673–1683PubMedCrossRef
93.
Zurück zum Zitat Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12):4195–4201PubMed Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12):4195–4201PubMed
94.
Zurück zum Zitat Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919–1923. doi:10.1182/blood-2010-04-279083 PubMedCrossRef Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919–1923. doi:10.​1182/​blood-2010-04-279083 PubMedCrossRef
97.
Zurück zum Zitat Nezelof C, Basset F (1998) Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12(2):385–406PubMedCrossRef Nezelof C, Basset F (1998) Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12(2):385–406PubMedCrossRef
98.
Zurück zum Zitat Shahla A, Parvaneh V, Hossein HD (2004) Langerhans cells histiocytosis in one family. Pediatr Hematol Oncol 21(4):313–320PubMedCrossRef Shahla A, Parvaneh V, Hossein HD (2004) Langerhans cells histiocytosis in one family. Pediatr Hematol Oncol 21(4):313–320PubMedCrossRef
99.
Zurück zum Zitat Fisher GM, Iqball S, Knight SC (1999) Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 11(2):111–117PubMedCrossRef Fisher GM, Iqball S, Knight SC (1999) Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 11(2):111–117PubMedCrossRef
100.
Zurück zum Zitat Dziegiel P, Dolilnska-Krajewska B, Dumanska M, Weclawek J, Jelen M, Podhorska-Okolow M, Jagoda E, Fic M, Zabel M (2007) Coexpression of CD1a, langerin and Birbeck’s granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 45(1):21–25PubMed Dziegiel P, Dolilnska-Krajewska B, Dumanska M, Weclawek J, Jelen M, Podhorska-Okolow M, Jagoda E, Fic M, Zabel M (2007) Coexpression of CD1a, langerin and Birbeck’s granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 45(1):21–25PubMed
101.
Zurück zum Zitat Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE, Limper AH (2003) The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 124(4):1199–1205PubMedCrossRef Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE, Limper AH (2003) The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 124(4):1199–1205PubMedCrossRef
102.
Zurück zum Zitat Fraig M, Shreesha U, Savici D, Katzenstein AL (2002) Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 26(5):647–653PubMedCrossRef Fraig M, Shreesha U, Savici D, Katzenstein AL (2002) Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 26(5):647–653PubMedCrossRef
104.
Zurück zum Zitat Ryu JH, Colby TV, Hartman TE, Vassallo R (2001) Smoking-related interstitial lung diseases: a concise review. Eur Respir J 17(1):122–132PubMedCrossRef Ryu JH, Colby TV, Hartman TE, Vassallo R (2001) Smoking-related interstitial lung diseases: a concise review. Eur Respir J 17(1):122–132PubMedCrossRef
105.
Zurück zum Zitat Liebow AA, Steer A, Billingsley JG (1965) Desquamative interstitial pneumonia. Am J Med 39:369–404PubMedCrossRef Liebow AA, Steer A, Billingsley JG (1965) Desquamative interstitial pneumonia. Am J Med 39:369–404PubMedCrossRef
106.
Zurück zum Zitat Valdivia E, Hensley G, Leory EP, Wu J, Jaeschke W (1977) Morphology and pathogenesis of desquamative interstitial pneumonitis. Thorax 32(1):7–18PubMedCrossRef Valdivia E, Hensley G, Leory EP, Wu J, Jaeschke W (1977) Morphology and pathogenesis of desquamative interstitial pneumonitis. Thorax 32(1):7–18PubMedCrossRef
107.
Zurück zum Zitat Singh G, Katyal SL, Whiteside TL, Stachura I (1981) Desquamative interstitial pneumonitis. The intra-alveolar cells are macrophages. Chest 79(1):128PubMedCrossRef Singh G, Katyal SL, Whiteside TL, Stachura I (1981) Desquamative interstitial pneumonitis. The intra-alveolar cells are macrophages. Chest 79(1):128PubMedCrossRef
108.
109.
Zurück zum Zitat Yousem SA (2006) Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol: an official Journal of the United States and Canadian Academy of Pathology, Inc 19(11):1474–1479. doi:10.1038/modpathol.3800671 Yousem SA (2006) Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol: an official Journal of the United States and Canadian Academy of Pathology, Inc 19(11):1474–1479. doi:10.​1038/​modpathol.​3800671
110.
Zurück zum Zitat Herschke F, Plumet S, Duhen T, Azocar O, Druelle J, Laine D, Wild TF, Rabourdin-Combe C, Gerlier D, Valentin H (2007) Cell–cell fusion induced by measles virus amplifies the type I interferon response. J Virol 81(23):12859–12871. doi:10.1128/jvi.00078-07 PubMedCrossRef Herschke F, Plumet S, Duhen T, Azocar O, Druelle J, Laine D, Wild TF, Rabourdin-Combe C, Gerlier D, Valentin H (2007) Cell–cell fusion induced by measles virus amplifies the type I interferon response. J Virol 81(23):12859–12871. doi:10.​1128/​jvi.​00078-07 PubMedCrossRef
111.
Zurück zum Zitat Delage G, Brochu P, Robillard L, Jasmin G, Joncas JH, Lapointe N (1984) Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med 108(8):623–625PubMed Delage G, Brochu P, Robillard L, Jasmin G, Joncas JH, Lapointe N (1984) Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med 108(8):623–625PubMed
112.
Zurück zum Zitat Katzenstein AL, Gordon LP, Oliphant M, Swender PT (1995) Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 19(4):439–447PubMedCrossRef Katzenstein AL, Gordon LP, Oliphant M, Swender PT (1995) Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 19(4):439–447PubMedCrossRef
113.
Zurück zum Zitat Mak H, Moser RL, Hallett JS, Robotham JL (1982) Usual interstitial pneumonitis in infancy. Clinical and pathologic evaluation. Chest 82(1):124–126PubMedCrossRef Mak H, Moser RL, Hallett JS, Robotham JL (1982) Usual interstitial pneumonitis in infancy. Clinical and pathologic evaluation. Chest 82(1):124–126PubMedCrossRef
114.
Zurück zum Zitat Reiterer F, Dornbusch HJ, Urlesberger B, Reittner P, Fotter R, Zach M, Popper H, Muller W (1999) Cytomegalovirus associated neonatal pneumonia and Wilson–Mikity syndrome: a causal relationship? Eur Respir J 13(2):460–462PubMedCrossRef Reiterer F, Dornbusch HJ, Urlesberger B, Reittner P, Fotter R, Zach M, Popper H, Muller W (1999) Cytomegalovirus associated neonatal pneumonia and Wilson–Mikity syndrome: a causal relationship? Eur Respir J 13(2):460–462PubMedCrossRef
115.
Zurück zum Zitat Euler AR, Byrne WJ, Ament ME, Fonkalsrud EW, Strobel CT, Siegel SC, Katz RM, Rachelefsky GS (1979) Recurrent pulmonary disease in children: a complication of gastroesophageal reflux. Pediatrics 63(1):47–51PubMed Euler AR, Byrne WJ, Ament ME, Fonkalsrud EW, Strobel CT, Siegel SC, Katz RM, Rachelefsky GS (1979) Recurrent pulmonary disease in children: a complication of gastroesophageal reflux. Pediatrics 63(1):47–51PubMed
116.
Zurück zum Zitat Castillo M, Vade A, Lim-Dunham JE, Masuda E, Massarani-Wafai R (2010) Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation. Pediatr Radiol 40(9):1562–1565. doi:10.1007/s00247-010-1670-2 PubMedCrossRef Castillo M, Vade A, Lim-Dunham JE, Masuda E, Massarani-Wafai R (2010) Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation. Pediatr Radiol 40(9):1562–1565. doi:10.​1007/​s00247-010-1670-2 PubMedCrossRef
118.
Zurück zum Zitat Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ (2002) Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 27(4):481–486PubMed Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ (2002) Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 27(4):481–486PubMed
119.
Zurück zum Zitat Ioachimescu OC, Kavuru MS (2006) Pulmonary alveolar proteinosis. Chron Respir Dis 3(3):149–159PubMedCrossRef Ioachimescu OC, Kavuru MS (2006) Pulmonary alveolar proteinosis. Chron Respir Dis 3(3):149–159PubMedCrossRef
120.
Zurück zum Zitat Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 276(4 Pt 1):L556–L563PubMed Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 276(4 Pt 1):L556–L563PubMed
121.
Zurück zum Zitat Trapnell BC, Whitsett JA (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775–802PubMedCrossRef Trapnell BC, Whitsett JA (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775–802PubMedCrossRef
122.
Zurück zum Zitat Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, Houdayer C, Elion J, Couderc R, Bahuau M (2004) Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet 126A(1):18–26PubMedCrossRef Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, Houdayer C, Elion J, Couderc R, Bahuau M (2004) Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet 126A(1):18–26PubMedCrossRef
124.
Zurück zum Zitat Whitsett JA, Wert SE, Trapnell BC (2004) Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 13(Spec No 2):R207–R215 Whitsett JA, Wert SE, Trapnell BC (2004) Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 13(Spec No 2):R207–R215
125.
Zurück zum Zitat Thomassen MJ, Raychaudhuri B, Bonfield TL, Malur A, Abraham S, Barna BP, Kavuru MS (2003) Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity 36(5):285–290PubMedCrossRef Thomassen MJ, Raychaudhuri B, Bonfield TL, Malur A, Abraham S, Barna BP, Kavuru MS (2003) Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity 36(5):285–290PubMedCrossRef
126.
Zurück zum Zitat Deterding RR, Pye C, Fan LL, Langston C (2005) Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol 40(2):157–165PubMedCrossRef Deterding RR, Pye C, Fan LL, Langston C (2005) Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol 40(2):157–165PubMedCrossRef
127.
Zurück zum Zitat Ioachimescu OC, Sieber S, Kotch A (2004) Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 24(1):162–170PubMedCrossRef Ioachimescu OC, Sieber S, Kotch A (2004) Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 24(1):162–170PubMedCrossRef
129.
Zurück zum Zitat Astrinidis A, Khare L, Carsillo T, Smolarek T, Au KS, Northrup H, Henske EP (2000) Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet 37(1):55–57PubMedCrossRef Astrinidis A, Khare L, Carsillo T, Smolarek T, Au KS, Northrup H, Henske EP (2000) Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet 37(1):55–57PubMedCrossRef
130.
Zurück zum Zitat Carsillo T, Astrinidis A, Henske EP (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 97(11):6085–6090PubMedCrossRef Carsillo T, Astrinidis A, Henske EP (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 97(11):6085–6090PubMedCrossRef
131.
Zurück zum Zitat Popper HH, Gamperl R, Pongratz MG, Kullnig P, Juttner-Smolle FM, Pfragner R (1993) Chromosome typing in lymphangioleiomyomatosis of the lung with and without tuberous sclerosis. Eur Respir J 6(5):753–759PubMed Popper HH, Gamperl R, Pongratz MG, Kullnig P, Juttner-Smolle FM, Pfragner R (1993) Chromosome typing in lymphangioleiomyomatosis of the lung with and without tuberous sclerosis. Eur Respir J 6(5):753–759PubMed
132.
Zurück zum Zitat Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP (1998) Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 62(4):810–815PubMedCrossRef Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP (1998) Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 62(4):810–815PubMedCrossRef
133.
Zurück zum Zitat Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, Bonetti F, Kingswood C (2010) European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35(1):14–26. doi:10.1183/09031936.00076209 PubMedCrossRef Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, Bonetti F, Kingswood C (2010) European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35(1):14–26. doi:10.​1183/​09031936.​00076209 PubMedCrossRef
134.
Zurück zum Zitat Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ Jr, Miles D, Cutler D, Krueger D, Uppot RN, Rabenou R, Camposano S, Paolini J, Fennessy F, Lee N, Woodrum C, Manola J, Garber J, Thiele EA (2011) Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease. PLoS One 6(9):e23379. doi:10.1371/journal.pone.0023379 PubMedCrossRef Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ Jr, Miles D, Cutler D, Krueger D, Uppot RN, Rabenou R, Camposano S, Paolini J, Fennessy F, Lee N, Woodrum C, Manola J, Garber J, Thiele EA (2011) Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease. PLoS One 6(9):e23379. doi:10.​1371/​journal.​pone.​0023379 PubMedCrossRef
135.
Zurück zum Zitat Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR (2011) Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res 17(12):4071–4081. doi:10.1158/1078-0432.ccr-11-0445 PubMedCrossRef Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR (2011) Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res 17(12):4071–4081. doi:10.​1158/​1078-0432.​ccr-11-0445 PubMedCrossRef
136.
Zurück zum Zitat McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP 3rd, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan EJ, Colby TV, McKay RT, Cohen MM, Korbee L, Taveira-DaSilva AM, Lee HS, Krischer JP, Trapnell BC (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364(17):1595–1606. doi:10.1056/NEJMoa1100391 PubMedCrossRef McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP 3rd, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan EJ, Colby TV, McKay RT, Cohen MM, Korbee L, Taveira-DaSilva AM, Lee HS, Krischer JP, Trapnell BC (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364(17):1595–1606. doi:10.​1056/​NEJMoa1100391 PubMedCrossRef
137.
Zurück zum Zitat Bittmann I, Rolf B, Amann G, Lohrs U (2003) Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol 34(1):95–98PubMedCrossRef Bittmann I, Rolf B, Amann G, Lohrs U (2003) Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol 34(1):95–98PubMedCrossRef
138.
Zurück zum Zitat Bittmann I, Dose TB, Muller C, Dienemann H, Vogelmeier C, Lohrs U (1997) Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol 28(12):1420–1423PubMedCrossRef Bittmann I, Dose TB, Muller C, Dienemann H, Vogelmeier C, Lohrs U (1997) Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol 28(12):1420–1423PubMedCrossRef
139.
Zurück zum Zitat Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP Jr, Wang JA, Kumaki F, Darling T, Moss J (2004) Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci USA 101(50):17462–17467PubMedCrossRef Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP Jr, Wang JA, Kumaki F, Darling T, Moss J (2004) Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci USA 101(50):17462–17467PubMedCrossRef
140.
Zurück zum Zitat Nine JS, Yousem SA, Paradis IL, Keenan R, Griffith BP (1994) Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 13(4):714–719PubMed Nine JS, Yousem SA, Paradis IL, Keenan R, Griffith BP (1994) Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 13(4):714–719PubMed
141.
Zurück zum Zitat O’Brien JD, Lium JH, Parosa JF, Deyoung BR, Wick MR, Trulock EP (1995) Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 151(6):2033–2036PubMed O’Brien JD, Lium JH, Parosa JF, Deyoung BR, Wick MR, Trulock EP (1995) Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 151(6):2033–2036PubMed
142.
Zurück zum Zitat Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, Mariuzzi GM (1993) Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 17(11):1092–1102PubMedCrossRef Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, Mariuzzi GM (1993) Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 17(11):1092–1102PubMedCrossRef
144.
Zurück zum Zitat Anderson PD, Huizing M, Claassen DA, White J, Gahl WA (2003) Hermansky–Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet 113(1):10–17PubMed Anderson PD, Huizing M, Claassen DA, White J, Gahl WA (2003) Hermansky–Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet 113(1):10–17PubMed
145.
Zurück zum Zitat Hermos CR, Huizing M, Kaiser-Kupfer MI, Gahl WA (2002) Hermansky–Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases. Hum Mutat 20(6):482PubMedCrossRef Hermos CR, Huizing M, Kaiser-Kupfer MI, Gahl WA (2002) Hermansky–Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases. Hum Mutat 20(6):482PubMedCrossRef
146.
Zurück zum Zitat Starcevic M, Nazarian R, Dell’Angelica EC (2002) The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky–Pudlak syndrome. Semin Cell Dev Biol 13(4):271–278PubMedCrossRef Starcevic M, Nazarian R, Dell’Angelica EC (2002) The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky–Pudlak syndrome. Semin Cell Dev Biol 13(4):271–278PubMedCrossRef
147.
Zurück zum Zitat Wei ML (2006) Hermansky–Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 19(1):19–42PubMedCrossRef Wei ML (2006) Hermansky–Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 19(1):19–42PubMedCrossRef
149.
Zurück zum Zitat Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, Myers JL (1999) Erdheim–Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 23(1):17–26PubMedCrossRef Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, Myers JL (1999) Erdheim–Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 23(1):17–26PubMedCrossRef
150.
Zurück zum Zitat Rush WL, Andriko JA, Galateau-Salle F, Brambilla E, Brambilla C, Ziany-bey I, Rosado-de-Christenson ML, Travis WD (2000) Pulmonary pathology of Erdheim–Chester disease. Mod Pathol 13(7):747–754PubMedCrossRef Rush WL, Andriko JA, Galateau-Salle F, Brambilla E, Brambilla C, Ziany-bey I, Rosado-de-Christenson ML, Travis WD (2000) Pulmonary pathology of Erdheim–Chester disease. Mod Pathol 13(7):747–754PubMedCrossRef
152.
Zurück zum Zitat Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, Hebisawa A, Yoshimura K (2006) Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration 73(4):481–487. doi:10.1159/000088684 PubMedCrossRef Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, Hebisawa A, Yoshimura K (2006) Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration 73(4):481–487. doi:10.​1159/​000088684 PubMedCrossRef
154.
155.
Zurück zum Zitat Benesch M, Kurz H, Eber E, Varga EM, Gopfrich H, Pfleger A, Popper H, Setinek-Liszka U, Zach MS (2001) Clinical and histopathological findings in two Turkish children with follicular bronchiolitis. Eur J Pediatr 160(4):223–226PubMedCrossRef Benesch M, Kurz H, Eber E, Varga EM, Gopfrich H, Pfleger A, Popper H, Setinek-Liszka U, Zach MS (2001) Clinical and histopathological findings in two Turkish children with follicular bronchiolitis. Eur J Pediatr 160(4):223–226PubMedCrossRef
156.
Zurück zum Zitat Glabe CG, Kayed R (2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66(2 Suppl 1):S74–S78PubMedCrossRef Glabe CG, Kayed R (2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66(2 Suppl 1):S74–S78PubMedCrossRef
157.
Zurück zum Zitat Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81(11):678–699PubMedCrossRef Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81(11):678–699PubMedCrossRef
158.
Zurück zum Zitat Westermark P (2005) Aspects on human amyloid forms and their fibril polypeptides. FEBS J 272(23):5942–5949PubMedCrossRef Westermark P (2005) Aspects on human amyloid forms and their fibril polypeptides. FEBS J 272(23):5942–5949PubMedCrossRef
159.
Zurück zum Zitat Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K (1988) Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 94(2):438–440PubMedCrossRef Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K (1988) Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 94(2):438–440PubMedCrossRef
160.
Zurück zum Zitat Marenco JL, Sanchez-Burson J, Ruiz Campos J, Jimenez MD, Garcia-Bragado F (1994) Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol 13(3):525–527PubMedCrossRef Marenco JL, Sanchez-Burson J, Ruiz Campos J, Jimenez MD, Garcia-Bragado F (1994) Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol 13(3):525–527PubMedCrossRef
161.
Zurück zum Zitat Kebbel A, Rocken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30(6):673–683PubMedCrossRef Kebbel A, Rocken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30(6):673–683PubMedCrossRef
162.
Zurück zum Zitat Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI (2002) Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 165(12):1654–1669PubMedCrossRef Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI (2002) Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 165(12):1654–1669PubMedCrossRef
163.
Zurück zum Zitat Chung MJ, Lee KS, Franquet T, Muller NL, Han J, Kwon OJ (2005) Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol 54(2):233–245PubMedCrossRef Chung MJ, Lee KS, Franquet T, Muller NL, Han J, Kwon OJ (2005) Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol 54(2):233–245PubMedCrossRef
164.
166.
Zurück zum Zitat Al-Alawi AS (2006) Familial occurrence of pulmonary alveolar microlithiasis in 3 siblings. Saudi Med J 27(2):238–240PubMed Al-Alawi AS (2006) Familial occurrence of pulmonary alveolar microlithiasis in 3 siblings. Saudi Med J 27(2):238–240PubMed
167.
Zurück zum Zitat Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A (2006) Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 79(4):650–656PubMedCrossRef Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A (2006) Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 79(4):650–656PubMedCrossRef
168.
Zurück zum Zitat Huqun IS, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K (2007) Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 175(3):263–268PubMedCrossRef Huqun IS, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K (2007) Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 175(3):263–268PubMedCrossRef
169.
Zurück zum Zitat Mariotta S, Ricci A, Papale M, De Clementi F, Sposato B, Guidi L, Mannino F (2004) Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 21(3):173–181PubMed Mariotta S, Ricci A, Papale M, De Clementi F, Sposato B, Guidi L, Mannino F (2004) Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 21(3):173–181PubMed
170.
Zurück zum Zitat Prakash UB (2002) Pulmonary alveolar microlithiasis. Semin Respir Crit Care Med 23(2):103–113PubMedCrossRef Prakash UB (2002) Pulmonary alveolar microlithiasis. Semin Respir Crit Care Med 23(2):103–113PubMedCrossRef
171.
Zurück zum Zitat Popper HH, Pailer S, Wurzinger G, Feldner H, Hesse C, Eber E (2002) Expression of adhesion molecules in allergic lung diseases. Virchows Arch 440(2):172–180PubMedCrossRef Popper HH, Pailer S, Wurzinger G, Feldner H, Hesse C, Eber E (2002) Expression of adhesion molecules in allergic lung diseases. Virchows Arch 440(2):172–180PubMedCrossRef
172.
Zurück zum Zitat Takatsu K, Nakajima H (2008) IL-5 and eosinophilia. Curr Opin Immunol 20:288–294 Takatsu K, Nakajima H (2008) IL-5 and eosinophilia. Curr Opin Immunol 20:288–294
175.
Zurück zum Zitat Bunc M, Remskar Z, Brucan A (2001) The idiopathic hypereosinophilic syndrome. Eur J Emerg Med 8(4):325–330PubMedCrossRef Bunc M, Remskar Z, Brucan A (2001) The idiopathic hypereosinophilic syndrome. Eur J Emerg Med 8(4):325–330PubMedCrossRef
176.
Zurück zum Zitat Lasfargues G, Lison D, Maldague P, Lauwerys R (1992) Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol Appl Pharmacol 112(1):41–50PubMedCrossRef Lasfargues G, Lison D, Maldague P, Lauwerys R (1992) Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol Appl Pharmacol 112(1):41–50PubMedCrossRef
177.
Zurück zum Zitat Lison D, Lauwerys R, Demedts M, Nemery B (1996) Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J 9(5):1024–1028PubMedCrossRef Lison D, Lauwerys R, Demedts M, Nemery B (1996) Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J 9(5):1024–1028PubMedCrossRef
178.
Zurück zum Zitat Naqvi AH, Hunt A, Burnett BR, Abraham JL (2008) Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumonitis): review of 100 cases. Arch Environ Occup Health 63(2):51–70. doi:10.3200/aeoh.63.2.51-70 PubMedCrossRef Naqvi AH, Hunt A, Burnett BR, Abraham JL (2008) Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumonitis): review of 100 cases. Arch Environ Occup Health 63(2):51–70. doi:10.​3200/​aeoh.​63.​2.​51-70 PubMedCrossRef
180.
Zurück zum Zitat Blanc PD (2007) Is giant cell interstitial pneumonitis synonymous with hard metal lung disease? Am J Respir Crit Care Med 176(8):834, author reply 834–835PubMed Blanc PD (2007) Is giant cell interstitial pneumonitis synonymous with hard metal lung disease? Am J Respir Crit Care Med 176(8):834, author reply 834–835PubMed
181.
Zurück zum Zitat Beinert T, Binder D, Stuschke M, Jorres RA, Oehm C, Fleischhacker M, Sezer O, Mergenthaler HG, Werner T, Possinger K (1999) Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 4(2):43–53PubMed Beinert T, Binder D, Stuschke M, Jorres RA, Oehm C, Fleischhacker M, Sezer O, Mergenthaler HG, Werner T, Possinger K (1999) Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 4(2):43–53PubMed
182.
Zurück zum Zitat Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C (2002) Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev 34(4):791–820PubMedCrossRef Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C (2002) Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev 34(4):791–820PubMedCrossRef
183.
Zurück zum Zitat Cohen GM (1990) Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ Health Perspect 85:31–41PubMedCrossRef Cohen GM (1990) Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ Health Perspect 85:31–41PubMedCrossRef
184.
Zurück zum Zitat Dinsdale D (1995) Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Int J Exp Pathol 76(6):393–401PubMed Dinsdale D (1995) Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Int J Exp Pathol 76(6):393–401PubMed
185.
Zurück zum Zitat Garrido M, O’Brien A, Gonzalez S, Clavero JM, Orellana E (2007) Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest 132(6):1997–1999PubMedCrossRef Garrido M, O’Brien A, Gonzalez S, Clavero JM, Orellana E (2007) Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest 132(6):1997–1999PubMedCrossRef
186.
Zurück zum Zitat Gupta S, Mahipal A (2007) Fatal pulmonary toxicity after a single dose of cyclophosphamide. Pharmacotherapy 27(4):616–618PubMedCrossRef Gupta S, Mahipal A (2007) Fatal pulmonary toxicity after a single dose of cyclophosphamide. Pharmacotherapy 27(4):616–618PubMedCrossRef
187.
Zurück zum Zitat Myers J, El-Zammar O (2006) Pathology of drug-induced lung disease. In: Katzenstein A, Askin F (eds) Surgical pathology of non-neoplastic lung disease, vol. 13. Major problems in pathology, 4th edn. Saunders Elsevier, Philadelphia Myers J, El-Zammar O (2006) Pathology of drug-induced lung disease. In: Katzenstein A, Askin F (eds) Surgical pathology of non-neoplastic lung disease, vol. 13. Major problems in pathology, 4th edn. Saunders Elsevier, Philadelphia
Metadaten
Titel
Interstitial lung diseases—can pathologists arrive at an etiology-based diagnosis? A critical update
verfasst von
Helmut H. Popper
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 1/2013
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1305-0

Weitere Artikel der Ausgabe 1/2013

Virchows Archiv 1/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …